未登录

Y

Yuan-Yuan Hei

fuzhou university

H指数:11

被引数:368

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interfacial Tandem Catalysis Over a CuSn(OH)₆/Co Heterostructure Enables Efficient Electroreduction of Nitrate to Ammonia

CuSn(OH)₆/Co异质结构界面串联催化实现硝酸根高效电还原为氨

Advanced Science

IF14.1

2026-09-090

OAAI

Synthesis and Frizzled-receptor binding of a WNT5A hairpin-3 peptide

CHEMICAL COMMUNICATIONS

IF4.2

2024-01-010

PRE

Proteotype coevolution and quantitative diversity across 11 mammalian species

SCIENCE ADVANCES

IF12.5

2022-09-0910

OAAI

Evolution of higher mesenchymal CD44 expression in the human lineage A gene linked to cancer malignancy

人类谱系中高间充质CD44表达的进化与癌症恶性相关的基因

EVOLUTION MEDICINE AND PUBLIC HEALTH

IF2.1

2022-08-305

OAAI

Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors

氟喹诺酮类microRNA-21小分子抑制剂的设计、合成与评价

JOURNAL OF PHARMACEUTICAL ANALYSIS

IF8.9

2022-08-0112

OAAI

Identification of benzamides derivatives of norfloxacin as promising microRNA-21 inhibitors via repressing its transcription

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2022-07-012

PRE

F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent

F10，一种新的喜树碱衍生物，被确定为一种新的口服生物可利用的，有效的抗肿瘤剂

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-09-0115

PREAI

Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-01-0152

PREAI

Alkylsulfonamide-containing quinazoline derivatives as potent and orally bioavailable PI3Ks inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2019-10-0115

PREAI

The dual luciferase reporter system and RT-qPCR strategies for screening of MicroRNA-21 small-molecule inhibitors

BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

IF2.7

2019-08-077

PREAI

Discovery of 2-(aminopyrimidin-5-yl)-4-(morpholin-4-yl)-6-substituted triazine as PI3K and BRAF dual inhibitor

FUTURE MEDICINAL CHEMISTRY

IF3.4

2018-10-1612

PREAI

Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2018-05-0124

PREAI

Synthesis and evaluation of 2,9-disubstituted 8-phenylthio/phenylsulfinyl-9H-purine as new EGFR inhibitors

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2018-05-0138

PREAI

Introduction of pyrrolidineoxy or piperidineamino group at the 4-position of quinazoline leading to novel quinazoline-based phosphoinositide 3-kinase delta (PI3Kδ) inhibitors

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2018-03-1410

OAAI

Discovery of 2,4,6-trisubstitued pyrido[3,4-d]pyrimidine derivatives as new EGFR-TKIs

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2018-03-0140

PREAI